Pax8 as a marker of Ovarian cancer Originating in the Fallopian tube

Project Information

PASCAL

Grant agreement ID: 618174

Project closed

Start date 1 December 2014

End date 30 November 2018

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 100 000,00

EU contribution € 100 000,00

Coordinated by

THE HEALTH CORPORATION - RAMBAM
Israel